Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Continuous ambulatory peritoneal dialysis].

B Faller1

  • 1Service de néphrologie, hôpital L. Pasteur, Colmar.

La Revue Du Praticien
|April 21, 1991
PubMed
Summary
This summary is machine-generated.

Continuous Ambulatory Peritoneal Dialysis (CAPD) offers a home-based alternative to hemodialysis for chronic kidney disease patients. Modern CAPD systems improve safety and are suitable for diverse patient groups, though long-term peritoneal function requires further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.

Pharmaceutical research·2016
Same author

A 5-year prospective follow-up study in essential cryofibrinogenemia patients.

Autoimmunity reviews·2011
Same author

Familial membranous glomerulopathy, toxic exposure and/or genetic sensibility?

Clinical nephrology·2008
Same author

First European combined heart, kidney, and pancreas transplantation 11 years after.

Transplantation proceedings·2001
Same author

High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.

Journal of medicinal chemistry·2001
Same author

Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network.

Journal of medicinal chemistry·2000
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Nephrology
  • Internal Medicine
  • Biomedical Engineering

Context:

  • Chronic renal failure necessitates dialysis, with hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) as primary treatment options.
  • CAPD involves home-based exchanges of dialysate via a permanent peritoneal catheter, utilizing gravity without machinery.
  • While short-term survival is comparable to HD, long-term CAPD efficacy and patient suitability are key considerations.

Purpose:

  • To evaluate Continuous Ambulatory Peritoneal Dialysis (CAPD) as a long-term dialysis treatment for chronic renal patients.
  • To compare CAPD with hemodialysis (HD) regarding short-term survival and long-term patient management.
  • To assess the impact of technological advancements on CAPD complications and patient applicability.

Summary:

Related Experiment Videos

  • CAPD is a permanent, machine-free dialysis for chronic renal patients, involving daily fluid exchanges.
  • Short-term survival rates for CAPD are comparable to HD; however, long-term management, especially residual renal function loss, requires attention.
  • Advancements like disconnect systems have significantly reduced peritonitis rates, and severe complications are decreasing, making CAPD suitable for home treatment across various patient demographics.

Impact:

  • CAPD provides a viable home-based dialysis option for a wide range of chronic kidney disease patients, including children, adults, diabetics, and the elderly.
  • Improved CAPD technology, particularly disconnect systems, has enhanced patient safety by reducing peritonitis and severe complications.
  • While CAPD shows promise, ongoing research is necessary to fully understand long-term peritoneal function and optimize patient outcomes.